Understanding how TGF-beta signaling affects brain cell interactions after a stroke
The role TGF-beta Signaling pathway in microglia and astrocytes homeostasis and cellular interactions
This study is looking at how two important brain cells, microglia and astrocytes, work together after a stroke, and it hopes to find ways to help brain cells survive and heal better by adjusting a specific signaling pathway.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11070309 on NIH RePORTER |
What this research studies
This research investigates the role of the TGF-beta signaling pathway in the interactions between microglia and astrocytes, two types of brain cells that play crucial roles in response to stroke. By examining how these cells communicate and respond to injury, the study aims to identify mechanisms that could enhance neuronal survival and recovery after a stroke. The researchers will use pharmacological modulators to explore how manipulating this pathway at different times can influence the inflammatory response and overall brain health. This work is essential for developing targeted therapies that could improve outcomes for stroke patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have experienced an ischemic stroke.
Not a fit: Patients who have not had a stroke or those with other neurological conditions unrelated to stroke may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery and reduce disability in stroke patients.
How similar studies have performed: While there have been mixed results in previous studies using TGF-beta modulators in stroke models, this research aims to provide a more precise understanding of its role, making it a novel approach.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Luo, Yu — University of Cincinnati
- Study coordinator: Luo, Yu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.